The potential utility of PFKFB3 as a therapeutic target

被引:79
作者
Bartrons, Ramon [1 ]
Rodriguez-Garcia, Ana [1 ]
Simon-Molas, Helga [1 ]
Castano, Esther [1 ]
Manzano, Anna [1 ]
Navarro-Sabate, Aurea [1 ]
机构
[1] Univ Barcelona, Dept Ciencies Fisiol, Unitat Bioquim, IDIBELL, Catalunya, Spain
关键词
Cancer; glycolysis; metabolism; PFKFB3; inhibitors; N-BROMOACETYLETHANOLAMINE PHOSPHATE; BREAST-CANCER CELLS; 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE GENE PFKFB3; APOPTOSIS REGULATOR TIGAR; ACTIVATED PROTEIN-KINASE; FRUCTOSE 2,6-BISPHOSPHATE; INDUCIBLE; 6-PHOSPHOFRUCTO-2-KINASE; GLUCOSE-METABOLISM; RHEUMATOID-ARTHRITIS; BIFUNCTIONAL ENZYME;
D O I
10.1080/14728222.2018.1498082
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: It has been known for over half a century that tumors exhibit an increased demand for nutrients to fuel their rapid proliferation. Interest in targeting cancer metabolism to treat the disease has been renewed in recent years with the discovery that many cancer-related pathways have a profound effect on metabolism. Considering the recent increase in our understanding of cancer metabolism and the enzymes and pathways involved, the question arises as to whether metabolism is cancer's Achilles heel.Areas covered: This review summarizes the role of 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in glycolysis, cell proliferation, and tumor growth, discussing PFKFB3 gene and isoenzyme regulation and the changes that occur in cancer and inflammatory diseases. Pharmacological options currently available for selective PFKFB3 inhibition are also reviewed.Expert opinion: PFKFB3 plays an important role in sustaining the development and progression of cancer and might represent an attractive target for therapeutic strategies. Nevertheless, clinical trials are needed to follow up on the promising results from preclinical studies with PFKFB3 inhibitors. Combination therapies with PFKFB3 inhibitors, chemotherapeutic drugs, or radiotherapy might improve the efficacy of cancer treatments targeting PFKFB3.
引用
收藏
页码:659 / 674
页数:16
相关论文
共 148 条
[71]   REGULATION OF 6-PHOSPHOFRUCTO-1-KINASE ACTIVITY IN RAS-TRANSFORMED RAT-1 FIBROBLASTS [J].
KOLE, HK ;
RESNICK, RJ ;
VANDOREN, M ;
RACKER, E .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 286 (02) :586-590
[72]  
Krebs H A, 1972, Essays Biochem, V8, P1
[73]   p53 in survival, death and metabolic health: a lifeguard with a licence to kill [J].
Kruiswijk, Flore ;
Labuschagne, Christiaan F. ;
Vousden, Karen H. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2015, 16 (07) :393-405
[74]  
Lea MA, 2016, ANTICANCER RES, V36, P1479
[75]   Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis [J].
Li, Fu-Long ;
Liu, Jin-Ping ;
Bao, Ruo-Xuan ;
Yan, GuoQuan ;
Feng, Xu ;
Xu, Yan-Ping ;
Sun, Yi-Ping ;
Yan, Weili ;
Ling, Zhi-Qiang ;
Xiong, Yue ;
Guan, Kun-Liang ;
Yuan, Hai-Xin .
NATURE COMMUNICATIONS, 2018, 9
[76]   Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator) [J].
Li, Hua ;
Jogl, Gerwald .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (03) :1748-1754
[77]   Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma [J].
Li, Hui-Min ;
Yang, Jie-Gang ;
Liu, Zhuo-Jue ;
Wang, Wei-Ming ;
Yu, Zi-Li ;
Ren, Jian-Gang ;
Chen, Gang ;
Zhang, Wei ;
Jia, Jun .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
[78]   By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma [J].
Li, Sainan ;
Dai, Weiqi ;
Mo, Wenhui ;
Li, Jingjing ;
Feng, Jiao ;
Wu, Liwei ;
Liu, Tong ;
Yu, Qiang ;
Xu, Shizan ;
Wang, Wenwen ;
Lu, Xiya ;
Zhang, Qinghui ;
Chen, Kan ;
Xia, Yujing ;
Lu, Jie ;
Zhou, Yingqun ;
Fan, Xiaoming ;
Xu, Ling ;
Guo, Chuanyong .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (12) :2571-2584
[79]   The molecular basis of targeting PFKFB3 as a therapeutic strategy against cancer [J].
Lu, Luo ;
Chen, Yaoyu ;
Zhu, Yu .
ONCOTARGET, 2017, 8 (37) :62793-62802
[80]   Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene (PFKFB3) [J].
Manzano, A ;
Rosa, JL ;
Ventura, F ;
Pérez, JX ;
Nadal, M ;
Estivill, X ;
Ambrosio, S ;
Gil, J ;
Bartrons, R .
CYTOGENETICS AND CELL GENETICS, 1998, 83 (3-4) :214-217